Koss Olinger Consulting LLC Takes $326,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Koss Olinger Consulting LLC acquired a new stake in HCA Healthcare, Inc., purchasing 943 shares valued at approximately $326,000.
• Analysts have mixed outlooks for HCA, with Barclays lowering their price target to $390.00 while multiple firms maintain various ratings ranging from "hold" to "strong buy".
• HCA Healthcare reported $6.84 EPS in its latest earnings, exceeding analyst expectations, with quarterly revenue of $18.61 billion.

Koss Olinger Consulting LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 943 shares of the company's stock, valued at approximately $326,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the first quarter worth $26,000. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the first quarter worth $28,000. Bartlett & CO. Wealth Management LLC increased its holdings in HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the last quarter. ORG Partners LLC increased its holdings in HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its position in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have commented on HCA. Barclays reduced their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research report on Monday, July 28th. JPMorgan Chase & Co. lifted their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Finally, Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $320.00 to $385.00 in a research report on Thursday, May 29th. Nine research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $395.69.

HCA Healthcare Stock Up 2.3%

HCA stock opened at $381.84 on Monday. The stock has a market capitalization of $89.35 billion, a P/E ratio of 16.05, a price-to-earnings-growth ratio of 1.20 and a beta of 1.39. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The firm has a 50-day moving average price of $369.74 and a 200-day moving average price of $349.53.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.50 earnings per share. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is currently 12.11%.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.